Cargando…
Cell-Free DNA for the Management of Classical Hodgkin Lymphoma
Cell-free DNA (cfDNA) testing, is an emerging “liquid biopsy” tool for noninvasive lymphoma detection, and an increased amount of data are now available to use this technique with accuracy, especially in classical Hodgkin lymphoma (cHL). The advantages of cfDNA include simplicity of repeated blood s...
Autores principales: | Camus, Vincent, Jardin, Fabrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998645/ https://www.ncbi.nlm.nih.gov/pubmed/33801462 http://dx.doi.org/10.3390/ph14030207 |
Ejemplares similares
-
P1217: TARGETING HSP110 IN COMBINATION WITH SELINEXOR IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA AND IN CLASSICAL HODGKIN LYMPHOMA INHIBITS STAT6 ACTIVATION AND IMPAIRS LYMPHOMA CELL GROWTH
por: Durand, Manon, et al.
Publicado: (2023) -
NFkB Pathway and Hodgkin Lymphoma
por: Jardin, Fabrice
Publicado: (2022) -
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study
por: Camus, Vincent, et al.
Publicado: (2020) -
Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma
por: Primerano, Simona, et al.
Publicado: (2016) -
Correlations between baseline (18)F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma
por: Decazes, Pierre, et al.
Publicado: (2020)